Miamo vs Hera

Miamo

Miamo is what happens when a Neapolitan pharmacist mother and her dermatology-trained daughter decide the existing dermocosmetic brands aren't doing enough. Founded in 2012 by Elena Aceto di Capriglia (the pharmacist) and Camilla D'Antonio (her daughter, who developed the patented ELPA25 peel after her own struggle with melasma), Miamo is a "functional cosmetics" house that sells through pharmacy channels — over 1,700 Italian pharmacies stock it, plus a UK launch in 2026. The lines are named like clinical protocols: Acnever (acne), Pigment Control (hyperpigmentation), Age Reverse (anti-aging), Restructuring (barrier repair). Active ingredient lists punch far above their price point — 5% niacinamide + hexylresorcinol + Brightenyl in the Triple Brightening Cream, tranexamic acid + tetrapeptide-30 in the Pigment Control Advanced Serum, ceramide + cholesterol + glycosphingolipids in the Essential Lipids Serum. The packaging is pharmacy-restrained, the marketing is education-led, and the brand is genuinely family-owned.

Pros

✓ pharmacist + dermatologist family ownership — genuine clinical credibility
✓ patented ELPA25 non-photosensitising peel and Epigenage epigenetic complex
✓ active concentrations that compete with Paula's Choice and SkinCeuticals
✓ 1,700+ Italian pharmacy distribution + UK rollout

Cons

✗ pharmacy-clinical packaging lacks aspirational design appeal
✗ international availability still expanding outside Italy/UK
✗ protocol-based naming (Acnever, Pigmencode) can feel medicalized
✗ fragrance-free positioning sometimes at odds with consumer-friendly textures

Hera

Hera is the AmorePacific-owned Korean luxury house that has produced one of the most photographed cushion compacts in beauty history (the Black Cushion) and a quietly excellent skincare lineup that doesn't get the same Sephora-front-row coverage as Sulwhasoo or Whoo. Premium pricing, Korean luxury heritage, formulations that earn their place at the top of any K-prestige routine.

Pros